Get the Stockscreener App
33.46
5.05%
-1.78
Pre-market:
31.80
-1.66
-4.96%
Nanobiotix Adr stock is traded at $33.46, with a volume of 203.16K.
It is down -5.05% in the last 24 hours and down -15.63% over the past month.
Nanobiotix SA is a late-stage clinical biotechnology company focused on re-inventing medicine by building new therapies atom by atom, developing widely applicable, first-in-class, physics-based nanotherapeutics to transform treatment outcomes and expand life for millions of patients. The objective of this physics-based approach is to allow nanoparticles to be combined with other drugs or therapeutic modalities and to integrate seamlessly into clinical practice without adding burden for the patient, healthcare provider, or healthcare system. It has three platforms Nanoradioenhancer platform: Nanoprimer platform: and Neurological disease platform. It has one segment, which is the research and development of product candidates that use proprietary nanotechnology to transform cancer treatment.
See More
Previous Close:
$35.24
Open:
$33.45
24h Volume:
203.16K
Relative Volume:
1.46
Market Cap:
$1.70B
Revenue:
$32.72M
Net Income/Loss:
$-27.55M
P/E Ratio:
-58.52
EPS:
-0.5718
Net Cash Flow:
$-41.40M
1W Performance:
-6.74%
1M Performance:
-15.63%
6M Performance:
+14.31%
1Y Performance:
+103.53%
1-Day Range:
$31.57
$34.65
1-Week Range:
$31.57
$36.10
52-Week Range:
$14.46
$57.14
Nanobiotix Adr Stock (NBTX) Company Profile
Compare NBTX vs VRTX, REGN, MRNA, ARGX, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NBTX
Nanobiotix Adr
|
33.46 | 1.70B | 32.72M | -27.55M | -41.40M | -0.5718 |
VRTX
Vertex Pharmaceuticals Inc
|
522.38 | 132.40B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
796.02 | 81.95B | 14.92B | 4.42B | 3.79B | 41.04 |
MRNA
Moderna Inc
|
194.82 | 77.78B | 2.23B | -3.19B | -1.60B | -8.1462 |
ARGX
Argen X Se Adr
|
962.22 | 60.20B | 4.16B | 1.29B | 734.26M | 19.58 |
RVMD
Revolution Medicines Inc
|
199.86 | 42.84B | 742.00K | -1.37B | -1.07B | -7.0731 |
Nanobiotix Adr Stock (NBTX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-06-26 | Initiated | TD Cowen | Buy |
| Aug-28-24 | Initiated | Guggenheim | Buy |
| Dec-08-23 | Initiated | Leerink Partners | Outperform |
| Jan-06-21 | Initiated | Evercore ISI | Outperform |
Nanobiotix Adr Stock (NBTX) Latest News
Nanobiotix S.A. (NBTX) Stock Price, News, Quote & History - ca.finance.yahoo.com
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday - Benzinga
Biophytis (BPTS) Peer Comparison – Compare with Others - valueresearchonline.com
Nanobiotix (NASDAQ:NBTX) Sees Large Volume IncreaseTime to Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap UpHere's What Happened - MarketBeat
Nanobiotix S.A.Sponsored ADR (NASDAQ:NBTX) Receives Consensus Rating of "Moderate Buy" from Brokerages - MarketBeat
Qatar Investment Authority (NBTX) reports 3.53M Nanobiotix ADRs under sole control - Stock Titan
Nanobiotix (NASDAQ:NBTX) Stock Price Down 5.4%What's Next? - MarketBeat
NBTXNanobiotix ADR Dividends - Finviz
NBTX Stock Price, Quote & Chart - ChartMill
5NRA Forecast — Price Target — Prediction for 2027 - TradingView
NANOBIOTIX Announces Closing of Global Offering - GlobeNewswire Inc.
NANOBIOTIX Announces Closing of Global Offering - Finansavisen
Nanobiotix Announces Temporary Trading Halt of Its Ordinary Shares on Euronext Paris - Barchart.com
XP posts downbeat Q1 earnings, joins Akamai Technologies and other big stocks moving lower in Tuesday's pre-market session - MSN
XP Posts Downbeat Q1 Earnings, Joins Akamai Technologies And Other Big Stocks Moving Lower In Tuesday's P - Benzinga
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer - ChartMill
Nanobiotix (NASDAQ:NBTX) Hits New 1-Year HighHere's What Happened - MarketBeat
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study - ChartMill
NBTX Forecast, Price Target & Analyst Ratings | NANOBIOTIX SAADR (NASDAQ:NBTX) - ChartMill
Nanobiotix (NASDAQ:NBTX) Trading 7.2% HigherShould You Buy? - MarketBeat
Nanobiotix (NASDAQ:NBTX) Shares Gap DownHere's What Happened - MarketBeat
Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology - ChartMill
Voting Rights and Shares Capital of the Company - Finansavisen
Nanobiotix H2 Earnings Call Highlights - Yahoo Finance
NANOBIOTIX to Announce Fourth Quarter and Full Year 2025 Operational and Financial Update on March 31st, 2026 - Finansavisen
Zenas Biopharma, Daqo New Energy and other big stocks moving lower in Friday's pre-market session - MSN
Zenas Biopharma, Daqo New Energy And Other Big Stocks Moving Lower In Friday's Pre-Market Session - Benzinga
NANOBIOTIX Statement Regarding Recent Media Speculation - ChartMill
BETA Technologies, Starfighters Space And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
NANOBIOTIX to Participate in Investor Conferences in March - Finansavisen
Semtech Posts Mixed Q3 Results, Joins Zhihu, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Ma - Benzinga
Outset Medical, Gemini Space Station, CoreWeave And Other Big Stocks Moving Lower In Tuesday's Pre-Market - Benzinga
Carter's, Newmont Corporation And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Karooooo Posts Downbeat Earnings, Joins ASP Isotopes And Other Big Stocks Moving Lower In Wednesday's Pre - Benzinga
Orion, Nio, Alibaba Group And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session - Benzinga
Why NioCorp Developments Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket - Benzinga
Nanobiotix announces regulatory harmonization, new patent for JNJ-1900 - TipRanks
symbol__ Stock Quote Price and Forecast - CNN
NANO Stock Price and Chart — EURONEXT:NANO - TradingView
Nanobiotix (NBTX) Stock Forecast and Price Target 2026 - MarketBeat
Nanobiotix Sa ADR Updates Share Capital Info - TipRanks
What is the current Price Target and Forecast for Nanobiotix S.A.Sponsored ADR (NBTX) - Zacks Investment Research
NanobiotixADR (NBTX) Dividend History, Date, and Yield - CoinCodex
Curious about the stocks that are showing activity before the opening bell on Tuesday? - ChartMill
Nanobiotix Adr Stock (NBTX) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.11%
1.87%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):